261 related articles for article (PubMed ID: 20600021)
21. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
22. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
[TBL] [Abstract][Full Text] [Related]
24. Use of human hepatocytes to investigate HCV infection.
Pichard-Garcia L; Briolotti P; Larrey D; Sa-Cunha A; Suc B; Laporte S; Maurel P
Methods Mol Biol; 2010; 640():447-62. PubMed ID: 20645067
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes.
Ray RB; Meyer K; Ray R
Virology; 2000 May; 271(1):197-204. PubMed ID: 10814584
[TBL] [Abstract][Full Text] [Related]
26. Production and characterization of HCV particles from serum-free culture.
Akazawa D; Morikawa K; Omi N; Takahashi H; Nakamura N; Mochizuki H; Date T; Ishii K; Suzuki T; Wakita T
Vaccine; 2011 Jun; 29(29-30):4821-8. PubMed ID: 21550372
[TBL] [Abstract][Full Text] [Related]
27. In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.
Gondeau C; Briolotti P; Razafy F; Duret C; Rubbo PA; Helle F; Rème T; Ripault MP; Ducos J; Fabre JM; Ramos J; Pécheur EI; Larrey D; Maurel P; Daujat-Chavanieu M
Gut; 2014 Sep; 63(9):1490-500. PubMed ID: 24153249
[TBL] [Abstract][Full Text] [Related]
28. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
Durand T; Di Liberto G; Colman H; Cammas A; Boni S; Marcellin P; Cahour A; Vagner S; Féray C
Gut; 2010 Jul; 59(7):934-42. PubMed ID: 20442199
[TBL] [Abstract][Full Text] [Related]
29. Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication.
von Hahn T; Schiene-Fischer C; Van ND; Pfaender S; Karavul B; Steinmann E; Potthoff A; Strassburg C; Hamdi N; Abdelaziz AI; Sarrazin C; Müller T; Berg T; Trépo E; Wedemeyer H; Manns MP; Pietschmann T; Ciesek S
Gastroenterology; 2012 Aug; 143(2):439-47.e1. PubMed ID: 22580540
[TBL] [Abstract][Full Text] [Related]
30. Cellular models for the screening and development of anti-hepatitis C virus agents.
Gondeau C; Pichard-Garcia L; Maurel P
Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
Bartenschlager R
Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
[TBL] [Abstract][Full Text] [Related]
32. Characterization of infectious hepatitis C virus from liver-derived cell lines.
Akazawa D; Date T; Morikawa K; Murayama A; Omi N; Takahashi H; Nakamura N; Ishii K; Suzuki T; Mizokami M; Mochizuki H; Wakita T
Biochem Biophys Res Commun; 2008 Dec; 377(3):747-51. PubMed ID: 18951878
[TBL] [Abstract][Full Text] [Related]
33. Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
Aly HH; Qi Y; Atsuzawa K; Usuda N; Takada Y; Mizokami M; Shimotohno K; Hijikata M
Hepatology; 2009 Sep; 50(3):689-96. PubMed ID: 19489071
[TBL] [Abstract][Full Text] [Related]
34. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle.
Albecka A; Belouzard S; Op de Beeck A; Descamps V; Goueslain L; Bertrand-Michel J; Tercé F; Duverlie G; Rouillé Y; Dubuisson J
Hepatology; 2012 Apr; 55(4):998-1007. PubMed ID: 22121002
[TBL] [Abstract][Full Text] [Related]
35. [HCV replication in Huh-7.5 cell line].
Komorowski M; Kołakowska A; Godzik P; Madaliński K
Med Dosw Mikrobiol; 2012; 64(3):239-44. PubMed ID: 23285778
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of an Huh.7.5.1-derived cell clone highly permissive to hepatitis C virus.
Shirasago Y; Sekizuka T; Saito K; Suzuki T; Wakita T; Hanada K; Kuroda M; Abe R; Fukasawa M
Jpn J Infect Dis; 2015; 68(2):81-8. PubMed ID: 25420655
[TBL] [Abstract][Full Text] [Related]
37. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection.
Yoshida T; Takayama K; Kondoh M; Sakurai F; Tani H; Sakamoto N; Matsuura Y; Mizuguchi H; Yagi K
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):119-24. PubMed ID: 22093821
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.
Weller R; Hueging K; Brown RJP; Todt D; Joecks S; Vondran FWR; Pietschmann T
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659481
[TBL] [Abstract][Full Text] [Related]
39. Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers.
Steenbergen RH; Joyce MA; Thomas BS; Jones D; Law J; Russell R; Houghton M; Tyrrell DL
Hepatology; 2013 Dec; 58(6):1907-17. PubMed ID: 23775894
[TBL] [Abstract][Full Text] [Related]
40. The specific infectivity of hepatitis C virus changes through its life cycle.
Keum SJ; Park SM; Park JH; Jung JH; Shin EJ; Jang SK
Virology; 2012 Nov; 433(2):462-70. PubMed ID: 22999258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
